|
MYO1D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.24199999995689E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.80339999999291E-05 |
| Normal-vs-Stage2 |
9.495700E-02 |
| Normal-vs-Stage3 |
1.408640E-01 |
| Normal-vs-Stage4 |
3.056800E-01 |
| Stage1-vs-Stage2 |
3.435400E-01 |
| Stage1-vs-Stage3 |
3.219800E-01 |
| Stage1-vs-Stage4 |
4.101400E-03 |
| Stage2-vs-Stage3 |
8.538000E-01 |
| Stage2-vs-Stage4 |
6.014000E-02 |
| Stage3-vs-Stage4 |
1.086800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.7250499999899E-05 |
| Normal-vs-AfricanAmerican |
1.883910E-02 |
| Normal-vs-Asian |
5.480600E-01 |
| Caucasian-vs-AfricanAmerican |
3.957800E-01 |
| Caucasian-vs-Asian |
5.447800E-01 |
| AfricanAmerican-vs-Asian |
7.125000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.63190000004965E-06 |
| Normal-vs-Female |
4.658300E-03 |
| Male-vs-Female |
8.819600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.234800E-01 |
| Normal-vs-Extreme_Weight |
5.441300E-04 |
| Normal-vs-Obese |
5.833700E-04 |
| Normal-vs-Extreme_Obese |
2.320600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.238770E-01 |
| Normal_Weight-vs-Obese |
9.196300E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.271600E-01 |
| Extreme_Weight-vs-Obese |
8.219200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.195400E-01 |
| Obese-vs-Extreme_Obese |
7.270600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.546190E-02 |
| Normal-vs-Age(41-60Yrs) |
2.96730000004519E-06 |
| Normal-vs-Age(61-80Yrs) |
5.538700E-03 |
| Normal-vs-Age(81-100Yrs) |
5.956400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.387800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.463600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.355370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.314320E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.092800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.601200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.21689999965646E-07 |
| Normal-VS-Type2 PRCC |
3.472200E-01 |
| Normal-VS-KIRP CIMP |
4.875700E-02 |
| Normal-VS-Unclassified PRCC |
6.014800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.558100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.516400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.838800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.433400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.505820E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.067800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.643570E-01 |
| Normal-vs-N1 |
4.271400E-01 |
| Normal-vs-N2 |
6.111200E-01 |
| N0-vs-N1 |
7.029000E-01 |
| N0-vs-N2 |
7.789400E-01 |
| N1-vs-N2 |
5.984400E-01 |
|
|
